Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ancient herb ashwagandha put to the test against asthma inflammation

NCT ID NCT07787507

Disease control Sponsor: Aligarh Muslim University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This trial tests whether ashwagandha (Withania somnifera) root powder, taken as a daily supplement for 10 weeks, can offer extra benefits for adults with moderate-to-severe asthma who are already on standard inhaler therapy. Researchers will measure changes in lung function, asthma control, quality of life, and markers of oxidative stress and inflammation. The study compares ashwagandha against a placebo to see if this traditional herb can help calm the airways and improve breathing.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Withania somnifera (ashwagandha) root powder as an add-on to standard asthma treatment
What this could lead to
If effective, ashwagandha could become a complementary therapy to help improve lung function and reduce inflammation in people with asthma.
What could go wrong
This is an early-stage trial with a modest number of participants, and results may not apply to all asthma patients. The supplement is tested alongside standard care, not as a replacement, and its benefits remain uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

120 people

The number who actually took part.

Started

Feb 2026

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 to 50 years Moderate to severe persistent asthma Non-smokers Receiving standard asthma medications for no more than one month Exclusion Criteria: * Recent respiratory tract infection Pregnant or lactating women Serious comorbid conditions Hospitalization within the previous one month

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Asthma

Contacts and locations

Locations

  • Aligarh Muslim University

    Aligarh, Uttar Pradesh, 202001, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.